$28.28 +0.35 (%) Pfizer Inc - NYSE

Oct. 21, 2014 | 04:00 PM

Partner Headlines

  1. Can Valeant's Strong Q3 Entice Allergan?

    IBD | Oct. 20, 2014 | 18:47PM EST
  2. Guru Stocks at 52-Week Lows: GOOG, PFE, UN, E, MTU

    GuruFocus | Oct. 20, 2014 | 12:03PM EST
  3. UPDATE: FDA Has Approved New Labeling on Pfizer's Embeda

    Benzinga | Oct. 17, 2014 | 16:27PM EST
  4. Baxter Q3 Beats As Hemophilia Drugs Fend Off Rivals

    IBD | Oct. 16, 2014 | 15:07PM EST
  5. Shire Can Thrive Without AbbVie, Say Analysts

    IBD | Oct. 16, 2014 | 11:19AM EST
  6. Shire Falls, AbbVie Questioned On Buyout Backtrack

    IBD | Oct. 15, 2014 | 13:11PM EST
  7. Fast Money Halftime Report Final Trade From October 13

    Benzinga | Oct. 13, 2014 | 16:17PM EST
  8. Alnylam Drug Scores Against Rare Nerve Disease

    IBD | Oct. 13, 2014 | 13:59PM EST
  9. Drugmaker M&A Goes On, With Or Without Tax Inversions

    IBD | Oct. 10, 2014 | 17:37PM EST
  10. Blackstone To Break-Up As Spin-Offs Ramp Up

    IBD | Oct. 10, 2014 | 11:02AM EST
  11. Actavis Finds Rx To Grow On Busy Drugmaker M&A Scene

    IBD | Oct. 7, 2014 | 18:33PM EST
  12. Actavis expands antibiotics

    IBD | Oct. 6, 2014 | 18:45PM EST
  13. Actavis Expands Antibiotics Presence With Durata Buy

    IBD | Oct. 6, 2014 | 10:58AM EST
  14. 10 Stocks With The Highest Share Buyback Volume In 2014

    GuruFocus | Oct. 3, 2014 | 13:52PM EST
  15. Tax Inversions Help Push Global M&A To 7-Year High

    IBD | Sep. 29, 2014 | 18:33PM EST
  16. Pfizer Inc. Stock Fails To Break Out: Is It Headed Back Down?

    Benzinga | Sep. 29, 2014 | 12:55PM EST
  17. Agios Pharmaceuticals Inc, Altria Group Inc Highlight CNBC's Stock Pops & Drops From September 26

    Benzinga | Sep. 27, 2014 | 10:33AM EST
  18. Focusing Solely On Animal Health Sets Zoetis Apart

    IBD | Sep. 26, 2014 | 14:37PM EST
  19. GlycoMimetics Reports Delay in Initiation of Phase 3 Trial with Rivipansel

    Benzinga | Sep. 26, 2014 | 09:03AM EST
  20. Fast Money Picks For September 26 - Pfizer Inc., The Dow Chemical Company And More

    Benzinga | Sep. 25, 2014 | 20:26PM EST
  21. A Few Reasons Why AbbVie's Momentum Will Continue

    GuruFocus | Sep. 25, 2014 | 17:53PM EST
  22. Pfizer

    IBD | Sep. 23, 2014 | 18:45PM EST
  23. Benzinga's M&A Chatter for Tuesday September 23, 2014

    Benzinga | Sep. 23, 2014 | 18:35PM EST
  24. Inversions Thwarted, But Real Tax Fix Needs Congress

    IBD | Sep. 23, 2014 | 18:28PM EST
  25. Stocks Finish Lower Among Takeover Rumors

    IBD | Sep. 23, 2014 | 18:06PM EST
  26. Stocks Fall To Session Lows; Vipshop Bucks The Trend

    IBD | Sep. 23, 2014 | 15:00PM EST
  27. Pfizer Inc. Is Kicking The Tires At Actavis PLC

    Benzinga | Sep. 23, 2014 | 14:45PM EST
  28. The Dogs of the Dow Lost Some Steam In The August Heat, But Maintained Their Lead

    GuruFocus | Sep. 16, 2014 | 16:58PM EST
  29. The Dogs of the Dow Lost Some Steam In The August Heat, But Maintained Their Lead

    GuruFocus | Sep. 16, 2014 | 15:16PM EST
  30. MedGenesis Announces Deal with Pfizer Related to Possible Treatments for Parkinson's

    Benzinga | Sep. 16, 2014 | 09:10AM EST
  31. Nasdaq Underperforms As Leading Growth Stocks Take Heat

    IBD | Sep. 15, 2014 | 11:49AM EST
  32. Benzinga's Weekend M&A Chatter

    Benzinga | Sep. 14, 2014 | 18:15PM EST
  33. Why Nine of Fifteen Oil Majors Are Undervalued

    YCharts | Sep. 12, 2014 | 18:34PM EST
  34. Pfizer Inc. Trying To Claw Its Way Back Up After Pullback

    Benzinga | Sep. 10, 2014 | 10:33AM EST
  35. Martoma Hit with Nine-Year Prison Sentence

    FoxBusiness | Sep. 8, 2014 | 16:44PM EST
  36. What Is A High Risk Market?

    Benzinga | Sep. 8, 2014 | 09:39AM EST
  37. Merck PD-1 Inhibitor Approved For Skin Cancer

    IBD | Sep. 4, 2014 | 16:33PM EST
  38. SunTrust Sees Further Pfizer Inc. Bid For AstraZeneca PLC 'Highly Likely'

    Benzinga | Sep. 2, 2014 | 15:35PM EST
  39. Partnering With Big Pharma, Parexel Hits Its Stride

    IBD | Aug. 29, 2014 | 16:14PM EST
  40. Amgen edges up on trial results

    IBD | Aug. 28, 2014 | 18:42PM EST
  41. I Am Sure This Pharma-Company Suits Your Portfolio

    GuruFocus | Aug. 28, 2014 | 13:52PM EST
  42. UPDATE: Protalix Shares Spike Higher on FDA Approval of Pediatric Indication for ELELYSO(TM) for Injection, for IV Use for Treatment of Type 1 Gaucher Disease

    Benzinga | Aug. 28, 2014 | 13:18PM EST
  43. Higher Yielding Stocks With A Cheap EV/EBITDA Ratio And Low Debt Figures

    GuruFocus | Aug. 28, 2014 | 12:21PM EST
  44. Fast Money Picks For August 28

    Benzinga | Aug. 27, 2014 | 20:35PM EST
  45. Markets Little Changed In Low Volume And Slow News Ahead Of Long Weekend

    Benzinga | Aug. 27, 2014 | 17:17PM EST
  46. Deutsche Bank Starts Pfizer, Lilly at Buy, Merck, Bristol-Myers at Hold

    Benzinga | Aug. 27, 2014 | 12:32PM EST
  47. Deutsche Bank Says Pfizer Has A Strong Financial Position And Attractive Pipeline

    Benzinga | Aug. 27, 2014 | 11:25AM EST
  48. Benzinga's Top Initiations

    Benzinga | Aug. 27, 2014 | 09:26AM EST
  49. Deutsche Bank Initiates Pfizer With Buy

    Benzinga | Aug. 27, 2014 | 07:06AM EST
  50. Merck, Pfizer combining drugs

    IBD | Aug. 26, 2014 | 18:45PM EST
Trading Center